Department of Molecular Biology and Genetic Engineering, C.B.S.H., G.B. Pant University of Agriculture & Technology, Pantnagar, 263145, Uttarakhand,India.
Curr Pharm Biotechnol. 2022;23(1):30-46. doi: 10.2174/1389201022666210122141724.
Cancer is amongst the leading public health problems globally with continuously increasing prevalence rate that demands for extensive and expensive treatment. Despite availability of number of potential cancer therapies, inadequate success has been achieved due to complexity and heterogeneity of tumors. Moreover, late/ terminal stage cancer leads to multidrug resistance, excruciating side effects, recurrence, etc. This is because of low penetrability and deleterious effects of drug on non-target cells/ tissues. This requires for cost effective, efficacious, alternative/ adjunct, complementary medicines with targeted drug delivery approach. A potential strategy to resolve this difficulty is to use theranostics i.e., formulations having both a therapeutic element and an imaging agent. Phytotherapeutics have been extensively used since times immemorial, having wide acceptability, easy availability, minimal side effects and comparatively inexpensive. These herbal formulations are mostly orally administered and thus subjected to adverse pH, enzymatic degradation, poor gut absorption, low bioavailability and non-targeted delivery that ultimately lead to their poor effectiveness. Constraints associated with conventional phyto-pharmaceuticals can be improved by designing and using "Nano Delivery Systems" (NDS). The foremost aim of metal based NDS is to provide sustained drug release, site-specific action, improved patient's compliance and enhanced efficacy. Metal Nanocarriers carrying herbal drugs will avoid these obstructions, so the drug can circulate into the blood for a longer period of time and provide optimal amount of the drug to the site of action. Besides, herbal drugs with NDS thus would be efficacious as alternative/ complementary cancer theranostics. Present review describes novel theranostic systems employing metal nanocarriers with diagnostic and therapeutic properties as an effective strategy for cancer treatment. These systems when conjugated with herbal drugs provide an efficient management strategy for cancer.
癌症是全球主要的公共卫生问题之一,其患病率不断上升,需要广泛而昂贵的治疗。尽管有许多潜在的癌症治疗方法,但由于肿瘤的复杂性和异质性,治疗效果并不理想。此外,晚期/终末期癌症导致多药耐药、剧烈的副作用、复发等。这是因为药物对非靶细胞/组织的穿透力低和有害作用。这需要具有成本效益、疗效高、替代/辅助、互补的药物,并采用靶向药物递送方法。解决这一难题的一种潜在策略是使用治疗诊断学,即具有治疗成分和成像剂的制剂。植物疗法自古就被广泛应用,具有广泛的可接受性、易于获得、副作用小、价格相对较低等优点。这些草药制剂大多是口服给药,因此会受到不良 pH 值、酶降解、肠道吸收不良、生物利用度低和非靶向递送的影响,最终导致疗效不佳。通过设计和使用“纳米给药系统”(NDS)可以改善传统植物药物的局限性。基于金属的 NDS 的首要目标是提供持续的药物释放、靶向作用、提高患者的依从性和增强疗效。携带草药药物的金属纳米载体将避免这些障碍,使药物能够在血液中循环更长时间,并将最佳剂量的药物输送到作用部位。此外,具有 NDS 的草药药物将作为替代/互补的癌症治疗诊断学具有疗效。本综述描述了新型治疗诊断系统,这些系统采用具有诊断和治疗特性的金属纳米载体,作为癌症治疗的有效策略。这些系统与草药药物结合使用,为癌症提供了一种有效的管理策略。